ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 15 of 31 for:    alzheimer dijon

A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02972658
Recruitment Status : Enrolling by invitation
First Posted : November 23, 2016
Last Update Posted : May 22, 2018
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : September 30, 2021
  Estimated Study Completion Date : September 30, 2021